title: Metastatic conversion of chemically transformed human cells.
abstract: A linear model for human cell metastasis has been developed in vitro from chemically transformed normal human cells. The chemically transformed cells are nontumorigenic in nude mice, but can be converted to a tumorigenic phenotype by transfection with a nondirectional cDNA library or antisense cDNA to the ML-1 gene. The primary transfected cell line (TR1T) forms localized, progressively growing tumors in nude mice that do not invade into the surrounding tissue. This tumorigenic TR1T cell line could be advanced into a metastatic stage following an additional transfection (TR2M cell line) with the cDNA expression library or antisense cDNA to the ML-1 gene. Metastatic cells, selected from tumors that were attached to internal organs, exhibited an increase in invasiveness as measured in vitro using an invasion chamber. The metastatic cells also exhibited an increased expression of matrix metalloproteinase-1 (MMP-1), although MMP-1 was not part of the cDNA that was transfected into either the TR1T cells or the doubly transfected metastatic TR2M cells. These data suggest that the increase in MMP-1 expression was a secondary downstream event responding to an upstream genetic change that initiated the conversion of cells from a tumorigenic to a metastatic stage. In summary, human cell lines representing premalignant, malignant, and metastatic phenotypes have been established in culture that can be used to identify gene changes that occur as normal human cells progress to a metastatic stage during tumor development. One gene, ML-1, that is found in the expression library appears to be involved in malignant progression, because ML-1 antisense cDNA will convert chemically transformed cells to both tumorigenic and metastatic stages, and cells from both local and metastatic tumors have a reduced or complete loss of expression of the ML-1 gene.
authors.affiliation: Department of Medical Biochemistry and Comprehensive Cancer Center, The Ohio State University College of Medicine and Public Health, Columbus 43210, USA. sun.73@osu.edu
authors.forename: X L
authors.initials: XL
authors.lastname: Sun
authors.forename: D
authors.initials: D
authors.lastname: Li
authors.forename: J
authors.initials: J
authors.lastname: Fang
authors.forename: B
authors.initials: B
authors.lastname: Casto
authors.forename: I
authors.initials: I
authors.lastname: Noyes
authors.forename: G E
authors.initials: GE
authors.lastname: Milo
mesh_terms: D000818:Animals; D015197:Carcinogenicity Tests; D002461:Cell Line, Transformed / Q000473:pathology*; D002471:Cell Transformation, Neoplastic / Q000187:drug effects* / Q000235:genetics*; D016373:DNA, Antisense / Q000494:pharmacology*; D015972:Gene Expression Regulation, Neoplastic; D016147:Genes, Tumor Suppressor; D006801:Humans; D008297:Male; D020781:Matrix Metalloproteinase 1 / Q000235:genetics; D051379:Mice; D008819:Mice, Nude; D009362:Neoplasm Metastasis; D009374:Neoplasms, Experimental / Q000473:pathology / Q000556:secondary; D019715:Tissue Inhibitor of Metalloproteinase-1 / Q000235:genetics
chemical_list: D016373:DNA, Antisense; D019715:Tissue Inhibitor of Metalloproteinase-1; D020781:Matrix Metalloproteinase 1